Vaccines
Studies from Federal University Provide New Data on Vaccines
Published in Vaccine Weekly, April 25th, 2012
2012 APR 25 -- Investigators discuss in "Immunological characterization of Mycoplasma hyopneumoniae recombinant proteins" new findings in Vaccines. According to the authors of a study from Pelotas, Brazil, "Mycoplasma hyopneumoniae, the primary pathogen of enzootic pneumonia, is highly prevalent worldwide and causes major economic losses to the pig industry. Commercial vaccines are widely used in the control of this disease, however, they provide only partial protection."
"The aim of this study was to evaluate 34 recombinant proteins of M. hyopneumoniae expressed in Escherichia coli. Antigenic and immunogenic properties of these proteins were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2012-04-25)
More Articles from Vaccine Weekly
- Vaccination
New Vaccination Study Findings Have Been Reported by Researchers at Brigham Young University - Vaccination
Research Reports on Vaccination from Brigham Young University Provide New Insights - Vaccine Development
Research in the Area of Vaccine Development Reported from Indian Institute of Science - Vaccination
Researchers' Work from Washington University Focuses on Vaccination - Vaccination
Studies on resistance against influenza - Gene Therapy
Bellicum Appoints Baylor College of Medicine's David M. Spencer as Chief Scientific Officer - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
